- Country: USA
- Summary: Tecovirimat
- UST Ref No: 126440453
- Deadline: 27 Sep 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 75A50325Q00027
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT
Agency: Department of Health and Human Services
Office: Administration for Strategic Preparedness and Response (ASPR), Center for the Strategic National Stockpile (SNS)
Location: 2945 Flowers Road, Atlanta GA, 30341
The NAICS code for this procurement is 325412, Pharmaceutical Preparation Manufacturing. The anticipated period of performance includes one (1) base year and two (2) one-year optional ordering periods.
The Office of the Administration for Strategic Preparedness and Response (ASPR), Center for the Strategic National Stockpile (SNS) intends to award a sole source firm fixed price contract to:
Manufacturer NameThe U.S. Government, in accordance with RFO 6.103-3 Industrial mobilization; engineering, developmental, or research capability; or expert services, intends to award a sole source contract to SIGA Technologies, Inc., 31 East 62nd Street, New York, NY 10065.
Requirement:
The Government requires replenishment and stockpiling of TPOXX™ (tecovirimat) 200 mg oral capsules and Tecovirimat injection (200 mg/vial, 10 mg/mL, single-dose) to support national biodefense and public health preparedness initiatives. Oral capsules provide the primary treatment option for patients able to take medication by mouth, while the IV formulation is critical for patients unable to swallow, with impaired absorption, or requiring inpatient care. Maintaining access to both dosage forms ensures operational flexibility and readiness to respond to orthopoxvirus threats, including smallpox.
Requirement:
387,096 QTY- Oral Capsules (200 mg): Store at 20°C-25°C (68°F-77°F); permitted excursions 15°C-30°C (59°F-86°F); protect from excessive heat and moisture.
525,030 QTY- IV Injection (200 mg/vial, 10 mg/mL): Store frozen at -20°C (-4°F);
Authority:
This acquisition will be conducted under the authority of RFO 6.103-3), which permits other than full and open competition ... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINTecovirimat - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE, a Government sector organization in USA, has announced a new tender for Tecovirimat. This tender is published on USARFP under UST Ref No: 126440453 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-27.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
